Soltesz Edward G, Cohn Lawrence H
Department of Surgery, Division of Cardiac Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Cardiol Rev. 2007 May-Jun;15(3):109-15. doi: 10.1097/01.crd.0000233769.92470.75.
Minimally invasive heart valve surgery has evolved significantly over the past 10 years and now comprises safe and efficient operations for most patients. The main goals of minimally invasive heart valve surgery are to reduce surgical trauma, increase patient satisfaction, reduce morbidity, and lower costs while still providing durable and safe valve repair or replacement. After a decade of refinements, studies have shown that minimally invasive heart valve surgery is a safe and effective procedure with similar if not improved perioperative morbidity and mortality rates compared with conventional valve surgery. Patients derive a variety of tangible benefits from these new surgical approaches, including less pain, shorter lengths of hospital stay, and faster return to preoperative functional levels. Minimally invasive heart valve surgery should be an option for any patient undergoing heart valve surgery today.
在过去十年中，微创心脏瓣膜手术有了显著发展，现在对大多数患者而言已包括安全且高效的手术。微创心脏瓣膜手术的主要目标是减少手术创伤、提高患者满意度、降低发病率并降低成本，同时仍能提供持久且安全的瓣膜修复或置换。经过十年的完善，研究表明，与传统瓣膜手术相比，微创心脏瓣膜手术是一种安全有效的手术，围手术期发病率和死亡率即便没有改善也相近。患者从这些新的手术方法中获得了各种切实的益处，包括疼痛减轻、住院时间缩短以及更快恢复到术前功能水平。如今，微创心脏瓣膜手术应成为任何接受心脏瓣膜手术患者的一种选择。
